Transactions
Jul. 9, 2002
PHARMACEUTICAL MAKER GOES ON FUNDING ODYSSEY
Odyssey Pharmaceuticals Inc. nabbed $15 million in its second round of funding, the San Ramon company announced June 24. HBM Partners led the round, which also included Burrill & Co., HealthCap, Cogene Biotech Ventures and Incyte Genomics.




HBM Partners led the round, which also included Burrill & Co., HealthCap, Cogene Biotech Ventures and Incyte Genomics.
Odyssey is a biopharmaceutical company that develops drugs to combat cancer, inflammati...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In